Answers are grounded in this paper and cite their sources.
Systematic review evaluates clinical efficacy and safety of Poly-L-Lactic Acid in dermatology, indicating long-term aesthetic benefits.
Background The rising demand for non‐invasive cosmetic procedures has led to increased use of biocompatible dermal fillers like Poly‐ l ‐Lactic Acid (PLLA), a synthetic, biodegradable polymer known for stimulating neocollagenesis and providing gradual, sustained volumization. Aim To comprehensively examine PLLA's development, properties, clinical efficacy, safety, and potential future directions in dermatological and aesthetic applications. Methods A systematic review and comparative clinical evaluation were conducted on PLLA's stereochemical structure, biostimulatory mechanisms, and outcomes. Comparisons with hyaluronic acid and calcium hydroxylapatite (CaHA) fillers were included. Results Studies revealed a 30% increase in collagen types I and III within 3 months post‐treatment. Around 80% of patients reported improved skin texture and volume. Mild adverse events (swelling, bruising) were reported in 35% of cases, while serious complications remained rare (0.4%). Advanced techniques—such as cannula use and microjet injection—have reduced complications, with nodule formation rates < 0.5% when proper protocols are followed. Compared to hyaluronic acid and calcium hydroxylapatite, PLLA provides superior long‐term aesthetic outcomes with minimal adverse effects. Conclusion PLLA offers a promising, long‐term alternative for skin rejuvenation. Continued innovation in formulation and delivery systems is expected to expand its dermatologic applications.
No takes yet. Share an insight, caveat, or question.
Mohammed et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: